DOR BIOPHARMA INC (DORB) is a publicly traded company in the Unknown sector. Across all available filings, 7 corporate insiders have executed 10 transactions totaling $16.6M, demonstrating a bullish sentiment with $16.6M in net insider flow. The most recent transaction on Sep 24, 2009 involved a purchase of 3,952,569 shares valued at $988.1K.
No significant insider buying has been recorded for DORB in the recent period.
No significant insider selling has been recorded for DORB in the recent period.
Based on recent SEC filings, insider sentiment for DORB is bullish with an Insider Alignment Score of 100/100 and a net flow of $16.6M. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
Insider trading at DOR BIOPHARMA INC (DORB) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 7 insiders are actively trading DORB stock, having executed 10 transactions in the past 90 days. The most active insider is Claudio Cavazza (Executive), who has made 2 transactions totaling $5.5M.
Get notified when executives and directors at DORB file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Sep 24, 2009 | Cavazza Claudio | Executive | Purchase | 3,952,569 | $0.25 | $988.1K | Large |
| Sep 24, 2009 | Cavazza Paolo | Executive | Purchase | 3,952,569 | $0.25 | $988.1K | Large |
| Sep 24, 2009 | S.a. Sigma-tau America | Executive | Purchase | 3,952,569 | $0.25 | $988.1K | Large |
| Feb 11, 2009 | Cavazza Claudio | Executive | Purchase | 25,000,000 | $0.18 | $4.5M | Large |
| Feb 11, 2009 | Cavazza Paolo | Executive | Purchase | 25,000,000 | $0.18 | $4.5M | Large |
| Feb 11, 2009 | Finanziaria Spa Sigma Tau | Executive | Purchase | 25,000,000 | $0.18 | $4.5M | Large |
| Aug 29, 2007 | Myrianthopoulos Evan | Executive | Purchase | 70,000 | $0.31 | $21.7K | |
| Aug 28, 2007 | J. Schaber Christopher | Executive | Purchase | 100,000 | $0.29 | $29.0K | |
| Aug 28, 2007 | Clavijo James | Executive | Purchase | 35,000 | $0.30 | $10.5K | |
| Feb 9, 2007 | J. Schaber Christopher | Executive | Purchase | 212,766 | $0.47 | $100.0K |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Purchase(P) | 10 | $16.6M | 100.0% |
Insiders at DOR BIOPHARMA INC are accumulating shares at an accelerated pace. With 7 insiders making 10 transactions totaling $16.6M in purchases versus $0 in sales, the net buying activity of $16.6M signals strong executive confidence. Claudio Cavazza (Executive) leads the buying activity with $5.5M in transactions across all time.